Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)

Shanghai Allist Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	20,187	18,747	8,856	13,590	12,816	-
Market Cap Growth	136.51%	111.69%	-34.83%	6.04%	-	-
Enterprise Value	17,233	16,494	6,916	11,015	12,083	-
Last Close Price	44.86	41.15	19.44	29.83	28.13	-
PE Ratio	18.43	28.78	67.03	745.80	-33.49	-
PS Ratio	7.07	9.29	11.20	25.64	22849.52	-
PB Ratio	4.47	4.71	2.78	4.57	4.45	-
P/FCF Ratio	17.35	30.90	-169.64	-83.40	-44.94	-
P/OCF Ratio	23.52	27.79	96.65	463.96	-65.14	-
EV/Sales Ratio	6.06	8.17	8.74	20.78	21543.30	-
EV/EBITDA Ratio	15.96	28.12	117.62	-196.69	-34.53	-
EV/EBIT Ratio	16.55	30.01	178.99	-157.79	-33.40	-
EV/FCF Ratio	14.81	27.18	-132.47	-67.60	-42.37	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	0.09
Debt / EBITDA Ratio	0.00	0.00	0.03	-	-	-
Debt / FCF Ratio	0.00	0.00	-0.04	-0.03	-	-0.32
Asset Turnover	-	0.52	0.24	0.17	0.00	0.00
Inventory Turnover	-	2.32	1.78	1.90	0.03	1.84
Quick Ratio	7.77	7.18	8.62	14.59	23.79	6.60
Current Ratio	7.97	7.46	8.98	15.21	24.58	6.86
Return on Equity (ROE)	-	17.97%	4.24%	0.62%	-15.29%	-63.33%
Return on Assets (ROA)	-	8.79%	0.73%	-1.43%	-10.48%	-29.04%
Return on Capital (ROIC)	-	9.58%	0.78%	-1.49%	-10.84%	-33.18%
Earnings Yield	5.43%	3.44%	1.47%	0.13%	-2.42%	-
FCF Yield	5.76%	3.24%	-0.59%	-1.20%	-2.23%	-
Dividend Yield	1.11%	0.97%	-	-	-	-
Buyback Yield / Dilution	1.09%	-0.09%	1.49%	-23.59%	-2.30%	-
Total Shareholder Return	2.20%	0.88%	1.49%	-23.59%	-2.30%	-

Source: S&P Capital IQ. Standard template. Financial Sources.